Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers

Samankaltaisia teoksia

• Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
  Tekijä: Mackay-Wiggan, Julian, et al.
  Julkaistu: (2016)
• Rapid Skin Repigmentation on Oral Ruxolitinib in a Patient with Coexistent Vitiligo and Alopecia Areata
  Tekijä: Harris, John E., et al.
  Julkaistu: (2015)
• An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis
  Tekijä: Jabbari, A, et al.
  Julkaistu: (2018)
• CXCR3 Blockade Inhibits T-cell Migration into the Skin and Prevents Development of Alopecia Areata
  Tekijä: Dai, Zhenpeng, et al.
  Julkaistu: (2016)
• Molecular signatures define alopecia areata subtypes and transcriptional biomarkers
  Tekijä: Jabbari, Ali, et al.
  Julkaistu: (2016)